New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
High cost of cancer drugs not always justified

High cost of cancer drugs not always justified

byUniversity of ZurichCredit: CC0 Public DomainA growing number of new cancer drugs have come on the market in recent years, yet the cost of therapies in Europe and the United States have risen.
World medicine December 07,2023
High cost of cancer drugs not always justified

High cost of cancer drugs not always justified

byUniversity of ZurichCredit: CC0 Public DomainA growing number of new cancer drugs have come on the market in recent years, yet the cost of therapies in Europe and the United States have risen.
World medicine December 07,2023
Drug overcomes chemotherapy resistance in ovarian cancer

Drug overcomes chemotherapy resistance in ovarian cancer

by Translational Research InstituteProfessor John Hooper. Credit: Mater ResearchAn international research team, led by scientists from Mater Research—The University of Queensland, have discovered they
World medicine December 07,2023
Drug overcomes chemotherapy resistance in ovarian cancer

Drug overcomes chemotherapy resistance in ovarian cancer

by Translational Research InstituteProfessor John Hooper. Credit: Mater ResearchAn international research team, led by scientists from Mater Research—The University of Queensland, have discovered they
World medicine December 07,2023
New thesis on the childhood malignancy Ewing sarcoma

New thesis on the childhood malignancy Ewing sarcoma

byKarolinska InstitutetCredit: CC0 Public DomainAsle Hesla from the group Orthopaedics will defend his thesis "Ewing Sarcoma—treatment, prognosis and late effects" on May 8th, 2020. Ma
World medicine December 07,2023
New thesis on the childhood malignancy Ewing sarcoma

New thesis on the childhood malignancy Ewing sarcoma

byKarolinska InstitutetCredit: CC0 Public DomainAsle Hesla from the group Orthopaedics will defend his thesis "Ewing Sarcoma—treatment, prognosis and late effects" on May 8th, 2020. Ma
World medicine December 07,2023
New toolbox for urological cancer detection

New toolbox for urological cancer detection

byUniversity of TurkuElectron microscopy image of the urinary extracellular vesicles studied. Credit: University of TurkuResearchers from Ghent University, Belgium, together with researchers fro
World medicine December 07,2023
New toolbox for urological cancer detection

New toolbox for urological cancer detection

byUniversity of TurkuElectron microscopy image of the urinary extracellular vesicles studied. Credit: University of TurkuResearchers from Ghent University, Belgium, together with researchers fro
World medicine December 07,2023
New AI model accurately classifies colorectal polyps using slides from 24 institutions

New AI model accurately classifies colorectal polyps using slides from 24 institutions

byDartmouth-Hitchcock Medical CenterVisualization of the classifications of the deep neural network model. The first column shows the original image, and the second column shows pathologist anno
World medicine December 07,2023
New AI model accurately classifies colorectal polyps using slides from 24 institutions

New AI model accurately classifies colorectal polyps using slides from 24 institutions

byDartmouth-Hitchcock Medical CenterVisualization of the classifications of the deep neural network model. The first column shows the original image, and the second column shows pathologist anno
World medicine December 07,2023
Cancer researchers find more effective way to deliver promising breast cancer treatment

Cancer researchers find more effective way to deliver promising breast cancer treatment

by Adrianna MacPherson,University of AlbertaU of A researchers Hasan Uludag (left) and Bindu Thapa are part of a team that developed a chemical compound that prompts cells to begin producing a p
World medicine December 07,2023
Cancer researchers find more effective way to deliver promising breast cancer treatment

Cancer researchers find more effective way to deliver promising breast cancer treatment

by Adrianna MacPherson,University of AlbertaU of A researchers Hasan Uludag (left) and Bindu Thapa are part of a team that developed a chemical compound that prompts cells to begin producing a p
World medicine December 07,2023
Multicancer blood test, PET-CT combo feasible for cancer screen

Multicancer blood test, PET-CT combo feasible for cancer screen

(HealthDay)—Multicancer blood testing combined with positron emission tomography-computed tomography (PET-CT) imaging can detect cancers, according to a study published online April 28 inScience
World medicine December 07,2023
Multicancer blood test, PET-CT combo feasible for cancer screen

Multicancer blood test, PET-CT combo feasible for cancer screen

(HealthDay)—Multicancer blood testing combined with positron emission tomography-computed tomography (PET-CT) imaging can detect cancers, according to a study published online April 28 inScience
World medicine December 07,2023
Gene signature found for poor response to standard chemotherapy in rare uterine cancer

Gene signature found for poor response to standard chemotherapy in rare uterine cancer

byMedical College of Georgia at Augusta UniversityDr. Jin-Xiong She and Lynn Tran. Credit: Phil Jones, Senior Photographer, Augusta UniversityWomen who don't survive a rare and aggressive ut
World medicine December 07,2023
Gene signature found for poor response to standard chemotherapy in rare uterine cancer

Gene signature found for poor response to standard chemotherapy in rare uterine cancer

byMedical College of Georgia at Augusta UniversityDr. Jin-Xiong She and Lynn Tran. Credit: Phil Jones, Senior Photographer, Augusta UniversityWomen who don't survive a rare and aggressive ut
World medicine December 07,2023
Early mammography screening lowers risk of developing fatal breast cancer

Early mammography screening lowers risk of developing fatal breast cancer

byWileyThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Ka
World medicine December 07,2023
Early mammography screening lowers risk of developing fatal breast cancer

Early mammography screening lowers risk of developing fatal breast cancer

byWileyThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli, Ph.D., and Ka
World medicine December 07,2023
What's old is new again: Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance

What's old is new again: Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance

byStowers Institute for Medical ResearchAnticancer immunity targeting therapy-resistant leukemia stem cells is activated by low-dose doxorubicin. Credit: Mark Miller, Stowers InstituteDrug resis
World medicine December 07,2023
What's old is new again: Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance

What's old is new again: Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance

byStowers Institute for Medical ResearchAnticancer immunity targeting therapy-resistant leukemia stem cells is activated by low-dose doxorubicin. Credit: Mark Miller, Stowers InstituteDrug resis
World medicine December 07,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com